Argonautica Private Wealth Management Inc. Boosts Stock Holdings in Smith & Nephew plc (NYSE:SNN)

Argonautica Private Wealth Management Inc. grew its stake in shares of Smith & Nephew plc (NYSE:SNN) by 4.5% during the 4th quarter, HoldingsChannel reports. The fund owned 10,362 shares of the medical equipment provider’s stock after buying an additional 449 shares during the period. Argonautica Private Wealth Management Inc.’s holdings in Smith & Nephew were worth $283,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in SNN. Ridgewood Investments LLC lifted its position in shares of Smith & Nephew by 33.5% during the third quarter. Ridgewood Investments LLC now owns 49,106 shares of the medical equipment provider’s stock worth $1,216,000 after acquiring an additional 12,316 shares in the last quarter. SVB Wealth LLC raised its position in shares of Smith & Nephew by 8.4% in the third quarter. SVB Wealth LLC now owns 12,487 shares of the medical equipment provider’s stock worth $309,000 after buying an additional 970 shares in the last quarter. Intellectus Partners LLC raised its position in shares of Smith & Nephew by 15.1% in the third quarter. Intellectus Partners LLC now owns 10,761 shares of the medical equipment provider’s stock worth $267,000 after buying an additional 1,413 shares in the last quarter. Park Avenue Securities LLC raised its position in shares of Smith & Nephew by 14.3% in the third quarter. Park Avenue Securities LLC now owns 26,271 shares of the medical equipment provider’s stock worth $651,000 after buying an additional 3,294 shares in the last quarter. Finally, Inspire Advisors LLC raised its position in shares of Smith & Nephew by 7.4% in the third quarter. Inspire Advisors LLC now owns 13,286 shares of the medical equipment provider’s stock worth $329,000 after buying an additional 919 shares in the last quarter. Hedge funds and other institutional investors own 25.64% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research report on Friday, March 15th. Three investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Smith & Nephew currently has a consensus rating of “Moderate Buy”.

Smith & Nephew Stock Up 2.4 %

SNN traded up $0.57 during trading on Friday, reaching $24.45. The stock had a trading volume of 1,759,851 shares, compared to its average volume of 922,038. The company has a quick ratio of 0.72, a current ratio of 1.77 and a debt-to-equity ratio of 0.44. Smith & Nephew plc has a one year low of $21.52 and a one year high of $33.08. The business has a 50-day moving average of $25.99 and a 200-day moving average of $25.97.

Smith & Nephew Dividend Announcement

The company also recently announced a semi-annual dividend, which will be paid on Wednesday, May 22nd. Investors of record on Tuesday, April 2nd will be paid a $0.462 dividend. The ex-dividend date is Monday, April 1st. This represents a yield of 2.8%.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.